Biotech deep tech funds invest at the intersection of biology and technology, backing companies that leverage AI-driven drug discovery, novel therapeutic modalities, and advanced diagnostics to fundamentally improve human health outcomes.
Showing 20 of 327 funds
Geneva, Switzerland
Boston, United States
Austin, United States
Menlo Park, United States
London, United Kingdom
Seattle, United States
Chicago, United States
San Francisco, United States
Waltham, United States
San Francisco, United States
Isle of Man, United Kingdom
London, United Kingdom
London, United Kingdom
Pasadena, United States
New York, United States
New York, United States
Stockholm, Sweden
Brooklyn, United States
Cambridge, United Kingdom
Berlin, Germany